Clinical Trial to Begin for New Alzheimer's Disease Treatment
Author: internet - Published 2021-05-02 07:00:00 PM - (195 Reads)The Northwest Clinical Research Center in Bellevue, Wash., is set to trial a potential Alzheimer's disease treatment that shows promise, reports the Bellevue Reporter . The therapy activates a naturally-occurring pathway, HGF/MET, to help deteriorated neural cells regenerate and improve cognitive function. The center's Arif Khan said the small molecule that triggers this mechanism, ATH-1017, should make neural cells more "young and active." Athira Pharma's Maggie Beller said the six-month trial will include up to 300 participants, with half receiving the daily treatment and the other half receiving a placebo. The treatment will involve daily injections into patients with mild to moderate Alzheimer's disease. If the data from this study proves positive, ATH-1017 could be investigated in both more severe and earlier-stage Alzheimer's patients.